Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Cells ; 31(3): 209-15, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21347705

RESUMEN

The therapeutic goal in treating cerebral ischemia is to reduce the extent of brain injury and thus minimize neurological impairment. We examined the effects of p-hydroxybenzyl alcohol (HBA), an active component of Gastrodia elata Blume, on transient focal cerebral ischemia-induced brain injury with respect to the involvement of protein disulphide isomerase (PDI), nuclear factor-E2-related factor 2 (Nrf2), and neurotrophic factors. All animals were ovariectomized 14 days before ischemic injury. Ischemic injury was induced for 1 h by middle cerebral artery occlusion (MCAO) followed by 24-h reperfusion. Three days before MCAO, the vehicle-treated and the HBA-treated groups received intramuscular sesame oil and HBA (25 mg/kg BW), respectively. 2,3,5-Triphenyltetrazolium chloride (TTC) staining showed decreased infarct volume in the ischemic lesion of HBA-treated animals. HBA pretreatment also promoted functional recovery, as measured by the modified neurological severity score (mNSS; p < 0.05). Moreover, expression of PDI, Nrf2, BDNF, GDNF, and MBP genes increased by HBA treatment. In vitro, H(2)O(2)-induced PC12 cell death was prevented by 24 h HBA treatment, but bacitracin, a PDI inhibitor, attenuated this cytoprotective effect in a dose-dependent manner. HBA treatment for 2 h also induced nuclear translocation of Nrf2, possibly activating the intracellular antioxidative system. These results suggest that HBA protects against brain damage by modulating cytoprotective genes, such as Nrf2 and PDI, and neurotrophic factors.


Asunto(s)
Alcoholes Bencílicos/farmacología , Lesiones Encefálicas/prevención & control , Lesiones Encefálicas/psicología , Isquemia Encefálica/tratamiento farmacológico , Factor 2 Relacionado con NF-E2/metabolismo , Factores de Crecimiento Nervioso/genética , Proteína Disulfuro Isomerasas/metabolismo , Animales , Bacitracina/farmacología , Conducta Animal/efectos de los fármacos , Lesiones Encefálicas/enzimología , Isquemia Encefálica/genética , Isquemia Encefálica/patología , Muerte Celular/efectos de los fármacos , Corteza Cerebral/patología , Cuerpo Estriado/patología , Modelos Animales de Enfermedad , Activación Enzimática , Femenino , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Peróxido de Hidrógeno/efectos adversos , Infarto de la Arteria Cerebral Media/patología , Examen Neurológico , Ovariectomía , Células PC12 , Proteína Disulfuro Isomerasas/antagonistas & inhibidores , Transporte de Proteínas/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Regulación hacia Arriba/efectos de los fármacos
2.
Toxicol Lett ; 152(1): 19-25, 2004 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-15294343

RESUMEN

The intestinal absorption of cadmium (Cd) is influenced by body iron (Fe) status in laboratory animals and humans. In this study we investigated the role of the apical Fe transporter divalent metal transporter 1 (DMT1) and the basolateral Fe exporter metal transporter protein 1 (MTP1) in Cd absorption. Rats were divided into the following groups; an Fe-sufficient (FeS) control group that was fed an FeS diet for 4 weeks (FeS, 4 weeks); an Fe-deficient (FeD) group that was fed an FeD diet for 4 weeks (FeD, 4 weeks); an FeS control group that was fed an FeS diet for 8 weeks (FeS, 8 weeks); an FeD/FeS group that was fed an FeD diet for 4 weeks and then an FeS diet for the following 4 weeks (FeD/FeS, 4 weeks/4 weeks); and an FeD group that was fed an FeD diet for 8 weeks (FeD, 8 weeks). After the 4- and 8-week feeding periods, rats were given a single oral gavage of Cd and were sacrificed 24 h later. The FeD (4 weeks) group developed Fe deficient anemia, but the parameters returned to control levels in the FeD/FeS group (4 weeks/4 weeks). The Cd body burden was greater in FeD (4 weeks) rats compared to FeS control (4 weeks), but returned to control Cd levels in FeD/FeS (4 weeks/4 weeks) rats. In addition, the expression of DMT1 and MTP1 was induced by Fe deficiency in the duodenum of FeD (4 weeks) rats, but was down-regulated to control values in FeD/FeS (4 weeks/4 weeks) rats. The correlation between duodenal DMT1 and MTP1 expression and Cd body burden in rats suggests an important role of DMT1 and MTP1 in Cd absorption.


Asunto(s)
Cadmio/farmacocinética , Proteínas de Transporte de Catión/fisiología , Hierro de la Dieta/farmacología , Proteínas de Unión a Hierro/fisiología , Absorción , Administración Oral , Animales , Carga Corporal (Radioterapia) , Cadmio/administración & dosificación , Sistema Digestivo , Masculino , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA